ECM Hydrogel Submucosal Cushion for Endoscopic GI Dissection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for effective agents in endoscopic procedures to dissect mucosa and submucosa from the muscularis propria in organs like the stomach, small intestine, and large intestine, while minimizing inflammation and facilitating minimally invasive treatments.

Innovation Solution

Injecting an extracellular matrix (ECM) hydrogel submucosally to form a cushion between the submucosa and the underlying muscularis propria, with characteristics of rapid gelation at 37°C, suitable viscosity for infusion, and stiffness of 10 to 400 Pascal (Pa) to facilitate dissection and reduce inflammation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If an ECM hydrogel is injected submucosally to form a cushion, then the dissection of mucosa and submucosa from muscularis propria is facilitated, but the gelation time and viscosity must be precisely controlled to ensure proper infusion and cushion formation

Engineering Contradiction:
Improveease of infusionVSAvoidhydrogel composition control
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by precisely controlling the viscosity and gelation time of the ECM hydrogel. The hydrogel is formulated with specific viscosity characteristics that allow it to be easily infused through catheters while maintaining the ability to form a stable cushion. The gelation time is optimized to occur within a specific window after injection, ensuring proper cushion formation without premature solidification.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes phase transitions by designing the ECM hydrogel to undergo gelation after injection. The hydrogel is injected in a liquid or semi-liquid state for easy infusion, then transitions to a gel state in situ to form the desired cushion structure. This phase transition enables the material to be easily administered while subsequently providing the structural integrity needed for effective dissection.

Inventive Principle:
Principle #36Phase transitions

2Strength

If the ECM hydrogel stiffness is increased to provide adequate cushion support, then dissection is facilitated, but the viscosity must remain suitable for infusion

Engineering Contradiction:
Improvecushion support strengthVSAvoidease of infusion
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The patent applies dynamics by creating a material that changes its mechanical properties over time. The ECM hydrogel is formulated to have low viscosity and stiffness during infusion to facilitate easy injection, then transitions to higher stiffness and structural integrity after gelation to provide adequate cushion support for dissection. This dynamic property change resolves the contradiction between ease of infusion and cushion support strength.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent applies preliminary action by ensuring the hydrogel is prepared with optimal viscosity characteristics before injection to facilitate easy infusion. The formulation is designed so that the infusion properties are optimized in advance, allowing the material to be easily administered before the gelation process begins and the stiffness increases to provide cushion support.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If the gelation time is reduced for faster cushion formation, then procedural efficiency is improved, but the viscosity must remain infusion-friendly

Engineering Contradiction:
Improveprocedural efficiencyVSAvoidhydrogel formulation
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by optimizing the gelation time of the ECM hydrogel to occur within a specific window that balances procedural efficiency with infusion characteristics. The formulation is designed to gel within a controlled time frame that allows adequate time for infusion but ensures rapid enough cushion formation to maintain procedural efficiency. The viscosity parameters are simultaneously optimized to remain infusion-friendly throughout the gelation process.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ECM hydrogel effectively dissects mucosa and submucosa from the muscularis propria, inhibiting inflammation and supporting endoscopic resection procedures in the gastrointestinal tract.

Implementation Method 1

a time to 50% gelation of less than 30 minutes at a temperature of about 37° C.

Methodology Applied
Scientific EffectGelation: Gel

Data Source

PatentUS12383243B2Extracellular matrix (ECM) hydrogel as a submucosal fluid cushion
Publication Date: 2025.08.12 UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
  • US12383243B2 patent drawing
  • US12383243B2 patent drawing
  • US12383243B2 patent drawing

AI summary

Methods are disclosed for dissecting a mucosa and a submucosa from a muscularis propria from a region of an organ of a subject, wherein the organ is not the esophagus. In some embodiments, the organ is in the gastrointestinal tract. These methods include injecting submucosally into the organ of the subject a pharmaceutical composition comprising an extracellular matrix (ECM) hydrogel to form a cushion between the submucosa and the underlying muscularis propria at the region of the organ, wherein the ECM hydrogel has the following characteristics: a) a time to 50% gelation of less than 30 minutes at a temperature of about 37° C.; b) a flow viscosity suitable for infusion into the organ; and c) a stiffness of about 10 to about 400 Pascal (Pa).